Company intelligence / Profile preview

Acare Technology

Xinzhuang District, New Taipei City, Taiwan

Ownership: Private
Development stage: Other

Overview

Acare Technology’s devices (notably the Auto-CPAP CPA-500) have demonstrated clinical efficacy; for example, CPA-500 showed an efficiency rate of 75.8%±15.8% for severe OSA cases in clinical studies by Wei-Sheng Chung, M.D, Ph.D at Taichung Hospital. All products are ISO13485/GMP certified, with strict quality control and regular FDA audits of the Taipei facility.

Therapeutic areas: Pulmonology
Modalities: Device (respiratory devices)Device (diagnostic equipment)Device (oxygen therapy equipment)Device (CPAP machines)Device (pulse oximeters)
Industry: Physiological Monitoring

Partnerships

Collaboration with ITRI (Industrial Technology Research Institute, Taiwan)

Beyond the preview

Go deeper on Acare Technology.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Acare Technology.

Explore the full profile